Citations

Clear

4847 citation(s) found for "Tu, Eric".

Cutaneous Electroanalgesia for Relief of Chronic and Neuropathic Pain
Smith, Thomas J. , Wang, Eric J. , Loprinzi, Charles L. , Smith, Thomas J , Wang, Eric

Mayo Clinic

New England Journal of Medicine | July 12, 2023 | Volume: 389 | Issue: 2 | Pages: 158-164

10.1056/nejmra2110098 | PMID 37437145 Get It

Cancer Cachexia: ASCO Guideline Rapid Recommendation Update
Bohlke, Kari , Baracos, Vickie E. , Smith, Thomas J. , Loprinzi, Charles L. , Panel, for the Cancer Cachexia Expert, Fabbro, Egidio Del , Dixon, Suzanne , Herrstedt, Jørn , Lau, Harold , Tan, Winston , Roeland, Eric J , Bohlke, Kari , Baracos, Vickie E , Smith, Thomas J , Loprinzi, Charles , Roeland, Eric , Panel, for the Cancer Cachexia Expert, Bruera, Eduardo , Fallon, Marie , Platek, Mary, Rugo, Hope S.

Mayo Clinic

Journal of Clinical Oncology | July 12, 2023 | Volume: 41 | Issue: 25 | Pages: 4178-4179

10.1200/jco.23.01280 | PMID 37467399 Get It

ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual . The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. See the Appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 , online only).
A nitroalkene derivative of salicylate alleviates diet-induced obesity by activating creatine metabolism and non-shivering thermogenesis
Cal, Karina, Leyva, Alejandro , Rodriguez-Duarte, Jorge, Ruiz, Santiago , Santos, Leonardo, Colella, Lucía, Ingold, Mariana , Vilaseca, Cecilia, Galliussi, Germán , Handy, Rachel, Reis, Larissa Menezes dos , Espasandín, Camila , Dapueto, Rosina , Thompson, Katie, Agorrody, Guillermo , DeVallance, Evan , Meadows, Ethan , Barbosa, Gabriele Santana, Souza, Leonardo Osbourne Lai de , Chichierchio, Marina Santos , Valez, Valeria , Aicardo, Adrián , Jakobsen, Steen, Kamaid, Andrés , Porcal, Williams , Calliari, Aldo , Wang, Yekai, Hollander, John M. , White, Thomas A. , Radí, Rafael , O’Doherty, Robert M. , Holloway, Graham P. , Kelley, Eric, Chini, Eduardo N. , Peclat, Thais R , Dos Reis, Larissa Menezes , Thompson, Katie L., Chichierchio, Marina Santos , Aicardo, Adrián , Contreras, Paola , White, Thomas A , Quijano, Celia , Moraes-Vieira, Pedro , Mori, Marcelo A , Lopez, Gloria V , Batthyány, Carlos , Chini, Eduardo Nunes , Escande, Carlos , Rodriguez‐Duarte, Jorge , Ziegler, Lucía , Peclat, Thais , Bresque, Mariana , Handy, Rachel, King, Rachel, Breining, Peter , Lopez, Andres, Lewis, Sara E. , Vendelbo, Mikkel Holm , Verdes, José Manuel , Du, Jianhai , Moyna, Guillermo , Leonardi, Roberta , Camacho-Pereira, Juliana , Durán, Rosario

Mayo Clinic

No container title available | July 12, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3101395/v1 | PMID 37502859 Get It

Abstract Obesity-related type II diabetes (diabesity) has increased global morbidity and mortality dramatically. Previously, the ancient drug salicylate demonstrated promise for the treatment of type II diabetes, but its clinical use was precluded due to high dose requirements. In this study, we present a nitroalkene derivative of salicylate, 5-(2-nitroethenyl)salicylic acid (SANA), a molecule with unprecedented beneficial effects in diet-induced obesity (DIO). SANA reduces DIO, liver steatosis and insulin resistance at doses up to 40 times lower than salicylate. Mechanistically, SANA stimulated mitochondrial respiration and increased creatine-dependent energy expenditure in adipose tissue. Indeed, depletion of creatine resulted in the loss of SANA action. Moreover, we found that SANA binds to creatine kinases CKMT1/2, and downregulation CKMT1 interferes with the effect of SANA in vivo. Together, these data demonstrate that SANA is a first-in-class activator of creatine-dependent energy expenditure and thermogenesis in adipose tissue and emerges as a candidate for the treatment of diabesity.
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Chiorean, E. Gabriela , Chiaro, Marco Del , Tempero, Margaret A. , Malafa, Mokenge P. , Benson, Al B. , Cardin, Dana B. , Christensen, Jared A. , Czito, Brian G. , Dillhoff, Mary , Donahue, Timothy R. , Hardacre, Jeffrey M., Klute, Kelsey , Ko, Andrew H. , LoConte, Noelle K. , Lowy, Andrew M. , Masood, Ashiq , Moravek, Cassadie, Nakakura, Eric K. , Narang, Amol , Nardo, Lorenzo , Obando, Jorge, Reddy, Sushanth , Reyngold, Marsha , Scaife, Courtney L. , Shen, Jeanne , Truty, Mark J. , Vollmer, Charles M., Wolff, Robert A. , Wolpin, Brian M. , McCullough, Beth, Lubin, Senem, Darlow, Susan, Cardin, Dana B , LoConte, Noelle , Chung, Vincent , Dotan, Efrat , Fountzilas, Christos , Glazer, Evan S. , Hawkins, William G , Kunstman, John W. , Polanco, Patricio Marcelo

Mayo Clinic

Journal of the National Comprehensive Cancer Network | July 11, 2023 | Volume: 21 | Issue: 7 | Pages: 753-782

10.6004/jnccn.2023.0034 | PMID 37433437 Get It

Ampullary cancers refer to tumors originating from the ampulla of Vater (the ampulla, the intraduodenal portion of the bile duct, and the intraduodenal portion of the pancreatic duct), while periampullary cancers may arise from locations encompassing the head of the pancreas, distal bile duct, duodenum, or ampulla of Vater. Ampullary cancers are rare gastrointestinal malignancies, and prognosis varies greatly based on factors such as patient age, TNM classification, differentiation grade, and treatment modality received. Systemic therapy is used in all stages of ampullary cancer, including neoadjuvant therapy, adjuvant therapy, and first-line or subsequent-line therapy for locally advanced, metastatic, and recurrent disease. Radiation therapy may be used in localized ampullary cancer, sometimes in combination with chemotherapy, but there is no high-level evidence to support its utility. Select tumors may be treated surgically. This article describes NCCN recommendations regarding management of ampullary adenocarcinoma.
HLA in isolated REM sleep behavior disorder and Lewy body dementia
Yu, Eric , Krohn, Lynne , Ruskey, Jennifer A. , Asayesh, Farnaz , Shah, Zalak , Hu, Michele T. M., Montplaisir, Jacques , Gagnon, Jean‐François , Désautels, Alex , Janes, Francesco , Bernardini, Andrea , Ibrahim, Abubaker , Heidbreder, Anna , Oertel, Wolfgang H. , Janzen, Annette , Figorilli, Michela , Puligheddu, Monica , Mollenhauer, Brit , Trenkwalder, Claudia , Sixel‐Döring, Friederike , Dijkstra, Femke, Viaene, Mineke , Abril, Beatriz, Scholz, Sonja W. , May, Patrick , Dauvilliers, Yves , Bernardini, Andrea , Stefani, Ambra , Janzen, Annette , Antelmi, Elena , Cochen De Cock, Valérie , Ferini-Strambi, Luigi , Rouleau, Guy Armand , Postuma, Ronald B , Scholz, Sonja W , Gan-Or, Ziv , May, Patrick , Ibrahim, Abubaker , Janes, Francesco , Figorilli, Michela , Puligheddu, Monica , Heidbreder, Anna , Spiegelman, Dan , Chia, Ruth , Arnulf, Isabelle , Hu, Michele T. M., Dauvilliers, Yves , Gigli, Gian Luigi , Valente, Mariarosaria , Högl, Birgit , Stefani, Ambra , Šonka, Karel , Dušek, Petr , Kemlink, David , Plazzi, Giuseppe , Antelmi, Elena , Boeve, Bradley F. , Postuma, Ronald B. , Gan‐Or, Ziv

Mayo Clinic

Annals of Clinical and Translational Neurology | July 4, 2023 | Volume: 10 | Issue: 9 | Pages: 1682-1687

10.1002/acn3.51841 | PMID 37401389 Get It

AbstractSynucleinopathies‐related disorders such as Lewy body dementia (LBD) and isolated/idiopathic REM sleep behavior disorder (iRBD) have been associated with neuroinflammation. In this study, we examined whether the human leukocyte antigen (HLA) locus plays a role in iRBD and LBD. In iRBD, HLA‐DRB1*11:01 was the only allele passing FDR correction (OR = 1.57, 95% CI = 1.27–1.93, p = 2.70e‐05). We also discovered associations between iRBD and HLA‐DRB1 70D (OR = 1.26, 95%CI = 1.12–1.41, p = 8.76e‐05), 70Q (OR = 0.81, 95%CI = 0.72–0.91, p = 3.65e‐04) and 71R (OR = 1.21, 95%CI = 1.08–1.35, p = 1.35e‐03). Position 71 (pomnibus = 0.00102) and 70 (pomnibus = 0.00125) were associated with iRBD. Our results suggest that the HLA locus may have different roles across synucleinopathies.
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral b
Morra, Anna , Schreurs, Maartje A. C. , Andrulis, Irene L. , Anton‐Culver, Hoda , Beckmann, Matthias W. , Bolla, Manjeet K. , Camp, Nicola J. , Cessna, Melissa H., Chang‐Claude, Jenny , Collaborators, NBCS, Dörk, Thilo , Easton, Douglas F. , Eccles, Diana M., Evans, D. Gareth , Fasching, Peter A. , Flyger, Henrik, García‐Closas, Montserrat , Graßmann, Felix , Gündert, Melanie , Hahnen, Eric , Haiman, Christopher A. , Hamann, Ute, Harrington, Patricia, Hoppe, Reiner , Hopper, John L. , Houlston, Richard S. , Howell, Anthony, Investigators, ABCTB, Investigators, kConFab, Janni, Wolfgang, John, Esther M. , Johnson, Nichola , Jones, Michael E. , Kristensen, Vessela N. , Kurian, Allison W. , Lambrechts, Diether , Lindblom, Annika , Mannermaa, Arto, Mavroudis, Dimitrios, Muranen, Taru , Nevelsteen, Ines, Neven, Patrick , Newman, William G. , Obi, Nadia , Offit, Kenneth , Park‐Simon, Tjoung‐Won , Patel, Alpa V. , Peterlongo, Paolo , Phillips, Kelly‐Anne , Plaseska‐Karanfilska, Dijana , Rack, Brigitte , Rhenius, Valerie , Romero, Atocha , Sawyer, Elinor J. , Schmutzler, Rita K. , Schuetze, Sabine, Shah, Mitul , Smichkoska, Snezhana , Tollenaar, Rob A.�E.�M. , Tomlinson, Ian , Vachon, Celine M. , Veen, Elke M. van , Wang, Qin , Wendt, Camilla, Wildiers, Hans , Pharoah, Paul D.P. , Adank, Muriel A. , Hooning, Maartje J. , Howell, Anthony , Ramus, Susan J. , Bojesen, Stig E. , Eccles, Diana , Cummings, Margaret C. , Loi, Sherene , Lambrechts, Diether , Howell, Sacha J. , Bojesen, Stig E , Dörk, Thilo , Figueroa, Jonine D , Gabrielson, Marike , Gago-Dominguez, Manuela , García-Sáenz, José A , Hahnen, Eric , Hartikainen, Jaana M , Jernström, Helena , John, Esther M , Lambrechts, Diether , Muranen, Taru A , Nevanlinna, H , Patel, Alpa V , Pylkäs, Katri , Rashid, Muhammad U , Hooning, Maartje J. , Lambrechts, Diether , Peterlongo, Paolo , Ramus, Susan J , Pharoah, Paul D P , Eccles, Diana , Houlston, Richard S , Anton-Culver, Hoda , Evans, D Gareth , Jones, Michael E , Newman, William G , Romero, Atocha , García-Closas, Montserrat , Kurian, Allison W , Loi, Sherene , Bojesen, Stig E , Phillips, Kelly-Anne , Wildiers, Hans , Lindblom, Annika , Plaseska-Karanfilska, Dijana , Sawyer, Elinor J , Augustinsson, Annelie , Behrens, Sabine , Brauch, Hiltrud , Broeks, Annegien , Buys, Saundra S. , Castelao, Jose E. , Chung, Wendy K. , Collaborators, NBCS, Colonna, Sarah V. , Couch, Fergus J. , Cox, Angela , Cross, Simon S. , Czene, Kamila , Daly, Mary Beryl , Dennis, Joe , Devilee, Peter , Dunning, Alison M. , Dwek, Miriam , Eriksson, Mikael , Fehm, Tanja , Figueroa, Jonine D. , Gabrielson, Marike , Gago-Domínguez, Manuela , García-Sáenz, José Á. , Genkinger, Jeanine M. , Hartikainen, Jaana M. , Howell, Anthony, Investigators, ABCTB, Investigators, kConFab, Jakubowska, Anna , Jernström, Helena , Marchand, Loı̈c Le , Lubiński, Jan , Lux, Michael P. , Mannermaa, Arto, Mulligan, Anna Marie , Nevanlinna, Heli , Olshan, Andrew F. , Polley, Eric C. , Presneau, Nadège , Pylkäs, Katri , Radice, Paolo , Rashid, Muhammad Usman , Robson, Mark E. , Saloustros, Emmanouil , Scott, Christopher G. , Southey, Melissa C. , Tapper, William , Teras, Lauren R. , Tomczyk, Katarzyna , Troester, Melissa A. , Vachon, Celine M. , Winqvist, Robert , Ziogas, Argyrios , Hall, Per N , Hollestelle, Antoinette , Schmidt, Marjanka K.

Mayo Clinic

Cancer Medicine | July 4, 2023 | Volume: 12 | Issue: 15 | Pages: 16142-16162

10.1002/cam4.6272 | PMID 37401034 Get It

Abstract Background Breast cancer (BC) patients with a germline CHEK2 c.1100delC variant have an increased risk of contralateral BC (CBC) and worse BC‐specific survival (BCSS) compared to non‐carriers. Aim To assessed the associations of CHEK2 c.1100delC, radiotherapy, and systemic treatment with CBC risk and BCSS. Methods Analyses were based on 82,701 women diagnosed with a first primary invasive BC including 963 CHEK2 c.1100delC carriers; median follow‐up was 9.1 years. Differential associations with treatment by CHEK2 c.1100delC status were tested by including interaction terms in a multivariable Cox regression model. A multi‐state model was used for further insight into the relation between CHEK2 c.1100delC status, treatment, CBC risk and death. Results There was no evidence for differential associations of therapy with CBC risk by CHEK2 c.1100delC status. The strongest association with reduced CBC risk was observed for the combination of chemotherapy and endocrine therapy [HR (95% CI): 0.66 (0.55–0.78)]. No association was observed with radiotherapy. Results from the multi‐state model showed shorter BCSS for CHEK2 c.1100delC carriers versus non‐carriers also after accounting for CBC occurrence [HR (95% CI): 1.30 (1.09–1.56)]. Conclusion Systemic therapy was associated with reduced CBC risk irrespective of CHEK2 c.1100delC status. Moreover, CHEK2 c.1100delC carriers had shorter BCSS, which appears not to be fully explained by their CBC risk.
Differentiation of hydrochlorothiazide-induced dermatitis from stasis dermatitis
Abdelwahab, Rewan , Tangalos, Eric G., Matulis, John C. , Matulis, John

Mayo Clinic

Drug and Therapeutics Bulletin | June 30, 2023 | Volume: 61 | Issue: 12 | Pages: 189-191

10.1136/dtb.2023.249884rep | PMID 37399277 Get It

Utility of CT and MRI in Tricuspid Valve Interventions
Reddy, Prajwal , Baliyan, Vinit , Hedgire, Sandeep, Foley, Thomas A. , Williamson, Eric E. , Eleid, Mackram F. , Rajiah, Prabhakar , Reddy, Prajwal , Hedgire, Sandeep S , Foley, Thomas , Williamson, Eric , Rajiah, Prabhakar

Mayo Clinic

RadioGraphics | June 29, 2023 | Volume: 43 | Issue: 7 | Pages: No page available

10.1148/rg.220153 | PMID 37384544 Get It

Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy
Yang, Binxia , McKeon, Andrew , Ahlskog, J. Eric , Tipton, Philip W. , Guo, Yong , Lucchinetti, Claudia F. , Pittock, Sean J. , Ζεκερίδου, Αναστασία , Brown, Andrew E. , Pittock, S J , Brown, Andrew , McKeon, Andrew , Tipton, Philip W , Lucchinetti, Claudia F , Zekeridou, Anastasia , Yang, Binxia , Brown, Andrew D.

Mayo Clinic

Annals of Neurology | June 28, 2023 | Volume: 94 | Issue: 3 | Pages: 502-507

10.1002/ana.26730 | PMID 37370243 Get It

Autoimmune movement disorders are increasingly recognized, but isolated tremor is extremely rare. We describe a 70‐year‐old male with rapidly progressive, severe postural and intention tremor and weight loss. His cerebrospinal fluid was inflammatory and harbored a neural tissue‐restricted antibody. The autoantigen was identified by immunoprecipitation and mass spectrometry and confirmed by antigen‐specific assays to be specific for tenascin‐R. He was investigated for cancer and diagnosed with follicular lymphoma that expressed tenascin‐R suggesting a paraneoplastic origin; cancer treatment and immunotherapy led to complete recovery. With this individualized patient approach and antibody discovery, we expand the spectrum of antibodies accompanying autoimmune hyperkinetic movement disorders. ANN NEUROL 2023;94:502–507
Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the
Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto , Blaise, Didier , Itälä‐Remes, Maija , Forcade, Édouard , Rabitsch, Werner , Bulabois, Claude‐Eric , Grillo, Giovanni , Rambaldi, Alessandro , Fanin, Renato , Zallio, Francesco, Renzo, Nicola Di , Novis, Yana , McDonald, Andrew , Herrera, Concha , Nagler, Arnon , Ciceri, Fabio , Blaise, Didier , Rambaldi, Alessandro , Labopin, Myriam , Bazarbachi, Ali , Vydra, Jan , Bramanti, Stéfania , Schmid, Christoph , Busca, Alessandro , Zecca, Marco , Kröger, Nicolaus , Koç, Yener , Sanz, Jaime , Mohty, Mohamad

Mayo Clinic

HemaSphere | June 27, 2023 | Volume: 7 | Issue: 7 | Pages: e920

10.1097/hs9.0000000000000920 | PMID 37388926 Get It

Availability of haploidentical donors has broadened utilization of allogeneic hematopoietic cell transplantation (allo-HCT). Peripheral blood stem cells (PBSC) are being used with increased frequency in haploidentical allo-HCT. We evaluated extent of HLA disparity (2–3/8 versus 4/8 HLA antigen mismatches) on post-allograft outcomes when using T-cell replete PBSC from haploidentical donors for acute myeloid leukemia in first complete remission. Primary objectives entailed assessing cumulative incidence of grade 2–4 acute graft-versus-host disease (GVHD) and chronic GVHD (any grade). A total of 645 patients received a haploidentical allo-HCT from a donor with either 2–3 of 8 HLA antigen mismatches (n = 180) or with 4 of 8 HLA antigen mismatches (n = 465). Presence of 2–3 of 8 versus 4 of 8 HLA mismatches did not affect the incidence of acute GVHD (grade 2–4) and chronic GVHD (any grade). Overall survival (OS), leukemia-free survival (LFS) relapse incidence (RI), nonrelapse mortality and the composite endpoint of GVHD-free relapse-free survival were also similar among the groups. Pertaining to HLA-B leader matching effect, our analysis did not discern any difference in aforementioned post-allograft outcomes for this variable. However, in univariate analysis, absence of an antigen mismatch in HLA-DPB1 showed a trend for better OS. Notwithstanding inherent limitations associated with registry data, our results did not show an advantage of selecting a haploidentical donor with 2–3 of 8 HLA antigen mismatches over one with 4 of 8 HLA antigen mismatches when using PBSC as the cell source. Adverse cytogenetics remains a major adverse determinant of inferior OS and LFS and a higher RI. Using reduced-intensity conditioning yielded worse OS and LFS.